| Authors: |
Ananthapadmanabhan V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Bruno S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA., Vonk L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Cheng YC; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Teshager A; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Eschle BK; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Howarth CL; Kymera Therapeutics, Inc., 500 North Beacon Street, Watertown, Massachusetts, USA., Rodrigues JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Schnabel J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA., Kodali A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Gokhale PC; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kshirsagar R; Kymera Therapeutics, Inc., 500 North Beacon Street, Watertown, Massachusetts, USA., Breitkopf SB; Kymera Therapeutics, Inc., 500 North Beacon Street, Watertown, Massachusetts, USA., Sharma K; Kymera Therapeutics, Inc., 500 North Beacon Street, Watertown, Massachusetts, USA., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Michor F; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; The Ludwig Center at Harvard, Boston, Massachusetts, USA., Chutake Y; Kymera Therapeutics, Inc., 500 North Beacon Street, Watertown, Massachusetts, USA., Dey J; Kymera Therapeutics, Inc., 500 North Beacon Street, Watertown, Massachusetts, USA., DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA. |
